Mario Schlosser compensation by year
Oscar Health Summary Compensation Table · all 6 fiscal years held| Component | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Salary | $493,750 | $430,000 | $495,681 | $600,000 | $600,000 | $600,000 |
| Bonus | $0 | $42,480 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $60,161,726 | $0 | $0 | $9,191,822 | $6,139,667 |
| Option awards | $0 | $0 | $0 | $0 | $0 | $0 |
| Non-equity incentive | $0 | $127,440 | $147,600 | $243,000 | $1,050,000 | $546,000 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $70,699 | $52,900 | $9,123 | $11,000 | $6,000 | $28,905 |
| Total | $564,449 | $60,814,546 | $652,405 | $854,000 | $10,847,822 | $7,314,572 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Oscar Health, Inc. DEF 14A filed April 22, 2026, accession 0001140361-26-016119, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Oscar Health, Inc. filed document, accession 0001140361-26-016119. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 172,269 | $2,475,506 | — |
| PSU | 171,935 | $2,470,706 | — |
| RSU | 129,705 | $1,863,861 | — |
| RSU | 129,202 | $1,856,633 | — |
| RSU | 72,059 | $1,035,488 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Oscar Health, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
40 Form 4 lines since the FY2025 proxy (filed April 22, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-09-03 | Sale | 10b5-1 | 31,422 | $31.45 | 449,444 |
| 2026-08-28 | Conversion derivative | — | 150,000 | $0.00 | 1,212,293 |
| 2026-08-28 | Conversion | — | 150,000 | — | 630,866 |
| 2026-08-28 | Sale | — | 150,000 | $30.79 | 480,866 |
| 2026-08-28 | Exercise or conversion derivative | — | 150,000 | $9.75 | 1,362,293 |
| 2026-08-28 | Exercise or conversion derivative | — | 150,000 | $0.00 | 2,990,000 |
| 2026-08-27 | Exercise or conversion derivative | — | 600,000 | $9.75 | 1,812,293 |
| 2026-08-27 | Sale | — | 600,000 | $30.34 | 480,866 |
The 8 most recent of 40 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Oscar Health discloses, by trigger · FY2024| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control, no termination | $0 | $0 | $0 | $0 |
| Involuntary termination without cause | $1,800,000 | $774,762 | $25,692 | $2,600,454 |
| Disability | $0 | $4,427,007 | $0 | $4,427,007 |
| Death | $0 | $4,427,007 | $0 | $4,427,007 |
| Change in control and involuntary termination | $1,800,000 | $5,145,925 | $25,692 | $6,971,617 |
Per the Potential Payments Upon Termination or Change in Control table in Oscar Health, Inc.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.
Oscar Health’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Janet Liang | President of Oscar Insurance | $10,400,673 |
| Mario Schlosser · this page | Co-Founder, President of Technology & Chief Technology Officer | $7,314,572 |
| Adam McAnaney | Chief Legal Officer | $7,129,097 |
| Scott Blackley | Chief Financial Officer | $4,752,808 |
| Mark Bertolini | Chief Executive Officer | $1,149,308 |
Board service
Oscar Health board · FY2021–FY2025How this board is paid
Company policy: Oscar Health pays directors a $70,000 cash retainer and $200,000 in RSUs. As stated in Oscar Health's FY2025 proxy.
Mario Schlosser's compensation dossier, Oscar Health
You have read Mario Schlosser's totals and holdings. The dossier adds each equity grant Oscar Health disclosed for Mario Schlosser and Oscar Health's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Oscar Health compensation record
free company briefThis page is one person within Oscar Health's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Oscar Health proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Oscar Health's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Oscar Health's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order OSCR
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.